Your browser doesn't support javascript.
loading
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
Omrani, Ali S; Zaqout, Ahmed; Baiou, Anas; Daghfal, Joanne; Elkum, Naser; Alattar, Rand A; Bakdach, Dana; Abusriwil, Hatem; Mostafa, Abdalrahman M; Alhariri, Bassem; Ambra, Naseem; Khatib, Mohamed; Eldeeb, Ali M; Merenkov, Zeyd; Fawzi, Zeinab; Hmissi, Saloua M; Hssain, Ali A; Coyle, Peter V; Alsoub, Hussam; Almaslamani, Muna A; Alkhal, Abdullatif.
Afiliación
  • Omrani AS; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Zaqout A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Baiou A; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Daghfal J; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Elkum N; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Alattar RA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Bakdach D; Research Department, Sidra Medical, Doha, Qatar.
  • Abusriwil H; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Mostafa AM; Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
  • Alhariri B; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Ambra N; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Khatib M; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Eldeeb AM; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Merenkov Z; Critical Care and Pulmonary Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Fawzi Z; Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar.
  • Hmissi SM; Transfusion Medicine, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Hssain AA; Transfusion Medicine, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Coyle PV; Transfusion Medicine, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Alsoub H; Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
  • Almaslamani MA; Division of Virology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Alkhal A; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
J Med Virol ; 93(3): 1678-1686, 2021 03.
Article en En | MEDLINE | ID: mdl-32965715
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasma / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Qatar
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasma / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Qatar